Plotted Points Statistics |
11-KETOTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 123% | 15% | 123% | 16% |
>= Reporting Level | 18 | 89% | 18% | 94% | 21% |
Total | 20 | 92% | 21% | 95% | 23% |
Sample Statistics |
11-KETOTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 20 | 80% | Spiked |
Estimated Values | 1 | 4% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 2 | 8% | Spiked |
Spiked | 26 | . | |
False Negatives | 3 | 12% | 3 out of 25 |
Not Spiked | 99 | . | |
False Positives | 1 | 1% | 1 out of 98 |
Plotted Points Statistics |
17-ALPHA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 62 | 86% | 14% | 86% | 13% |
Total | 62 | 86% | 14% | 86% | 13% |
Sample Statistics |
17-ALPHA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 62 | 98% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 1 | 2% | 1 out of 63 |
Not Spiked | 61 | . | |
False Positives | 0 | 0% | 0 out of 61 |
BQS OBSP Determination: |
17-ALPHA-ETHYNYLESTRADIOL |
SCHEDULE: 4434 , TESTIDCODE: 64529GM005 |
Open Data Set |
Plotted Points Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 60 | 81% | 16% | 80% | 15% |
Total | 60 | 81% | 16% | 80% | 15% |
Sample Statistics |
17-ALPHA-ETHYNYLESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 60 | 95% | Spiked |
Estimated Values | 4 | 6% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 3 | 5% | 3 out of 63 |
Not Spiked | 61 | . | |
False Positives | 0 | 0% | 0 out of 61 |
Plotted Points Statistics |
17-BETA-ESTRADIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 63 | 85% | 15% | 85% | 13% |
Total | 63 | 85% | 15% | 85% | 13% |
Sample Statistics |
17-BETA-ESTRADIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 63 | 100% | Spiked |
Estimated Values | 2 | 3% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 0 | 0% | 0 out of 63 |
Not Spiked | 61 | . | |
False Positives | 1 | 2% | 1 out of 61 |
Plotted Points Statistics |
3-BETA-COPROSTANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 53 | 109% | 91% | 93% | 17% |
Total | 53 | 109% | 91% | 93% | 17% |
Sample Statistics |
3-BETA-COPROSTANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 53 | 95% | Spiked |
Estimated Values | 2 | 4% | Spiked |
Deleted Values | 5 | 4% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 3 | 5% | 3 out of 56 |
Not Spiked | 55 | . | |
False Positives | 4 | 8% | 4 out of 53 |
BQS OBSP Determination: |
4-ANDROSTENE-3,17-DIONE |
SCHEDULE: 4434 , TESTIDCODE: 64533GM005 |
Open Data Set |
Plotted Points Statistics |
4-ANDROSTENE-3,17-DIONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 33 | 73% | 22% | 75% | 21% |
Total | 33 | 73% | 22% | 75% | 21% |
Sample Statistics |
4-ANDROSTENE-3,17-DIONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 97% | Spiked |
Estimated Values | 1 | 3% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 35 | . | |
False Negatives | 0 | 0% | 0 out of 34 |
Not Spiked | 90 | . | |
False Positives | 2 | 2% | 2 out of 89 |
Plotted Points Statistics |
BISPHENOL A |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 107% | 10% | 106% | 4% |
>= Reporting Level | 36 | 78% | 20% | 77% | 18% |
Total | 41 | 82% | 22% | 81% | 19% |
Sample Statistics |
BISPHENOL A |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 41 | 93% | Spiked |
Estimated Values | 4 | 9% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 7% | Spiked |
Spiked | 45 | . | |
False Negatives | 0 | 0% | 0 out of 44 |
Not Spiked | 78 | . | |
False Positives | 0 | 0% | 0 out of 78 |
Plotted Points Statistics |
CHOLESTEROL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 56 | 118% | 87% | 99% | 17% |
Total | 56 | 118% | 87% | 99% | 17% |
Sample Statistics |
CHOLESTEROL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 100% | Spiked |
Estimated Values | 1 | 2% | Spiked |
Deleted Values | 5 | 4% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 59 | . | |
False Negatives | 0 | 0% | 0 out of 56 |
Not Spiked | 55 | . | |
False Positives | 6 | 11% | 6 out of 53 |
Plotted Points Statistics |
CIS-ANDROSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 83% | 27% | 80% | 16% |
Total | 46 | 83% | 27% | 80% | 16% |
Sample Statistics |
CIS-ANDROSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 96% | Spiked |
Estimated Values | 7 | 15% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 2% | Spiked |
Spiked | 48 | . | |
False Negatives | 1 | 2% | 1 out of 48 |
Not Spiked | 77 | . | |
False Positives | 0 | 0% | 0 out of 75 |
Plotted Points Statistics |
DIHYDROTESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 168% | 91% | 156% | 98% |
>= Reporting Level | 24 | 67% | 28% | 66% | 11% |
Total | 33 | 95% | 69% | 69% | 17% |
Sample Statistics |
DIHYDROTESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 33 | 94% | Spiked |
Estimated Values | 8 | 23% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 3% | Spiked |
Spiked | 35 | . | |
False Negatives | 1 | 3% | 1 out of 35 |
Not Spiked | 90 | . | |
False Positives | 0 | 0% | 0 out of 89 |
Plotted Points Statistics |
EPITESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 58% | 18% | 52% | 5% |
>= Reporting Level | 46 | 82% | 23% | 74% | 15% |
Total | 51 | 79% | 23% | 74% | 17% |
Sample Statistics |
EPITESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 51 | 100% | Spiked |
Estimated Values | 8 | 16% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 53 | . | |
False Negatives | 0 | 0% | 0 out of 51 |
Not Spiked | 72 | . | |
False Positives | 2 | 3% | 2 out of 72 |
Plotted Points Statistics |
EQUILENIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 46 | 75% | 29% | 76% | 34% |
Total | 46 | 75% | 29% | 76% | 34% |
Sample Statistics |
EQUILENIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 46 | 94% | Spiked |
Estimated Values | 8 | 16% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 49 | . | |
False Negatives | 3 | 6% | 3 out of 49 |
Not Spiked | 61 | . | |
False Positives | 10 | 17% | 10 out of 60 |
Plotted Points Statistics |
EQUILIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 71% | 18% | 64% | 1% |
>= Reporting Level | 51 | 66% | 33% | 64% | 21% |
Total | 56 | 66% | 32% | 64% | 19% |
Sample Statistics |
EQUILIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 56 | 82% | Spiked |
Estimated Values | 56 | 82% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 70 | . | |
False Negatives | 11 | 16% | 11 out of 68 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
ESTRIOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 132% | 149% | 83% | 11% |
>= Reporting Level | 60 | 79% | 20% | 76% | 17% |
Total | 68 | 85% | 55% | 77% | 17% |
Sample Statistics |
ESTRIOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 68 | 91% | Spiked |
Estimated Values | 11 | 15% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 3% | Spiked |
Spiked | 76 | . | |
False Negatives | 5 | 7% | 5 out of 75 |
Not Spiked | 49 | . | |
False Positives | 3 | 6% | 3 out of 49 |
Plotted Points Statistics |
ESTRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 67 | 90% | 26% | 85% | 29% |
Total | 67 | 90% | 26% | 85% | 29% |
Sample Statistics |
ESTRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 67 | 97% | Spiked |
Estimated Values | 6 | 9% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 69 | . | |
False Negatives | 1 | 1% | 1 out of 69 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 54 |
Plotted Points Statistics |
MESTRANOL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 143% | . | 143% | 0% |
>= Reporting Level | 60 | 75% | 50% | 56% | 25% |
Total | 61 | 76% | 50% | 56% | 26% |
Sample Statistics |
MESTRANOL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 61 | 88% | Spiked |
Estimated Values | 3 | 4% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 69 | . | |
False Negatives | 7 | 10% | 7 out of 69 |
Not Spiked | 56 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
NORETHINDRONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 1 | 105% | . | 105% | 0% |
>= Reporting Level | 57 | 81% | 19% | 76% | 20% |
Total | 58 | 81% | 19% | 76% | 21% |
Sample Statistics |
NORETHINDRONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 58 | 92% | Spiked |
Estimated Values | 7 | 11% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 64 | . | |
False Negatives | 5 | 8% | 5 out of 63 |
Not Spiked | 61 | . | |
False Positives | 0 | 0% | 0 out of 60 |
Plotted Points Statistics |
PROGESTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 12 | 74% | 34% | 80% | 32% |
>= Reporting Level | 47 | 52% | 25% | 48% | 13% |
Total | 59 | 57% | 28% | 50% | 19% |
Sample Statistics |
PROGESTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 59 | 86% | Spiked |
Estimated Values | 59 | 86% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 8 | 12% | Spiked |
Spiked | 70 | . | |
False Negatives | 2 | 3% | 2 out of 69 |
Not Spiked | 55 | . | |
False Positives | 0 | 0% | 0 out of 55 |
Plotted Points Statistics |
TESTOSTERONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 36 | 87% | 14% | 85% | 11% |
Total | 36 | 87% | 14% | 85% | 11% |
Sample Statistics |
TESTOSTERONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 36 | 100% | Spiked |
Estimated Values | 2 | 6% | Spiked |
Deleted Values | 2 | 2% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 36 | . | |
False Negatives | 0 | 0% | 0 out of 36 |
Not Spiked | 89 | . | |
False Positives | 0 | 0% | 0 out of 87 |
BQS OBSP Determination: |
TRANS-DIETHYLSTILBESTROL |
SCHEDULE: 4434 , TESTIDCODE: 64536GM005 |
Open Data Set |